Hannah J. Thomas

Internal Medicine
100 E Lancaster Ave
Wynnewood, PA 19096

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Cis-targeted IL-2 mutein to augment the anti-tumor activity of engineered T cells.

Cis-targeted IL-2 mutein to augment the anti-tumor activity of engineered T cells.

Journal: Transplantation and cellular therapy
Published: May 23, 2026
Showing 1-1 of 1

Last Updated: 09/26/2026